Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Renal Failure|February 20, 2025
Safety and tolerability of molnupiravir and nirmatrelvir/ritonavir in patients with advanced chronic kidney disease and kidney failure; a cohort studyRani Sawtell, Tianqi Ouyang, Daiana Moreno, et al.Kidney360|November 22, 2024
Novel Biomarkers and Imaging Tests for Acute Kidney Injury Diagnosis in Patients with CancerKavita Mistry, Sagar Sadarangani, Daiana Moreno, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 25, 2023
Brief Report: Use and Side Effects of Sodium-Glucose Transporter 2 Inhibitors Among US People With HIV With Clinical IndicationsMeghan E Sise, Nurit Katz-Agranov, Ian A Strohbehn, et al.Plos One|February 27, 2023
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney functionRituvanthikaa Seethapathy, Qiyu Wang, Sophia Zhao, et al.Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFRPaul E Hanna, Qiyu Wang, Ian Strohbehn, et al.JAMA Network Open|July 5, 2023
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With CancerPaul E Hanna, Qiyu Wang, Ian A Strohbehn, et al.NPJ Breast Cancer|August 19, 2023
Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancerPaul E Hanna, Ian A Strohbehn, Daiana Moreno, et al.Journal of Cachexia, Sarcopenia and Muscle|April 22, 2024
Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancerPaul E Hanna, Tianqi Ouyang, Ismail Tahir, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 30, 2025
Sarcopenia, Elevated Body Mass Index, and Platinum-Associated Adverse Events in Patients With Lung CancerJiaxuan Lyu, Lea Mantz, Nurit S Katz-Agranov, et al.Journal for Immunotherapy of Cancer|January 19, 2023
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritisMeghan E Sise, Qiyu Wang, Harish Seethapathy, et al.Pageof 1